ArticleMedical oncology (Northwood, London, England)2024
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology.
K P Ameya et al.PubMed ↗Publisher ↗
No numbers read from the abstract.